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v-Src activity results in both morphological transformation and reentry of quiescent chick
embryo fibroblasts (CEF) into cell cycle. We have previously used temperature-sensitive
v-Src mutants to show that enhanced activity of cellular AP-1 in the first few hours after
activation of v-Src invariably precedes the biological consequences. Here we have inves-
tigated whether the early activation of AP-1 is essential for any or all of the v-Src responses
by using a mutant c-Fos that comprises the leucine zipper and a disrupted basic region.
Expression of the c-Fos mutant partially reduced cellular AP-1 activity in exponentially
growing cells. However, in CEF that had been made quiescent by serum deprivation, v-
Src-induced stimulation of AP-1 DNA binding activity was substantially reduced. In ad-
dition, quiescent CEF stably transfected with this mutant show an impaired mitogenic
response to v-Src, indicating that the AP-1 stimulation is a necessary prerequisite for cell-
cycle reentry. The ability of v-Src to morphologically transform quiescent CEF was not
impaired by the inhibition of AP-1 stimulation, indicating that the mitogenic and mor-
phological consequences of v-Src have distinguishable biochemical mediators. Focal adhe-
sion kinase, a recently identified determinant of cell morphology, undergoes a gel mobility
shift, characteristic of its hyperphosphorylated state, in response to v-Src activation in cells
expressing the inhibitory AP-1 protein. This provides further evidence that the pathways
that regulate morphological transformation are independent of AP-1.
INTRODUCTION
The v-Src oncoprotein transforms fibroblasts in cul-
ture and can stimulate quiescent rat and chicken fi-
broblasts to reenter cell cycle (Bell et al., 1975; Durkin
and Whitfield, 1984; Welham et al., 1990; Catling et
al., 1993). Recent evidence implies that v-Src initiates
events at the cell periphery, primarily signaling pro-
tein interactions mediated by the Src homology (SH)-
2 and SH3 domains (reviewed in Pawson and Schles-
singer, 1993) and protein tyrosine phosphorylations,
which in turn activate intracellular effector systems
and give rise to altered gene expression in the nucleus.
Although many parallels have been drawn between
growth factor receptor- and v-Src-mediated signaling
and putative mediators identified, the pathways by
* Current address: Department of Biochemistry and Molecular Ge-
netics, St. Mary's Hospital Medical School, Imperial College, Norfolk
Place, London W2 1PG, United Kingdom.
which v-Src transforms cells still remain to be eluci-
dated. In particular, the specific events that distin-
guish the oncogenic stimulus provided by v-Src from
the growth stimulus of growth factors are not well
understood.
Key transcription factors are involved in coupling
signals at the cell periphery to gene expression in the
nucleus by binding to specific DNA target sequences in
the promoters of responsive genes. AP-1 is one tran-
scription factor involved in the conversion of signals
provided by activated growth factor receptors, onco-
genes, and protein kinase C into the altered gene
expression that underlies the biological consequences
of these stimuli. AP-1 is dimeric, comprising members
of the Jun and Fos families. The first nuclear response
to growth factor-induced mitogenic signaling is rapid
induction of the "immediate-early" class of genes,
which includes c-fos and c-jun, whose stimulation is
important for exit from Go and cell-cycle progression.
In addition to transcriptional stimulation, AP-1 DNA
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binding and transactivation activities can also be reg-
ulated by posttranslational mechanisms in response to
biological stimuli, including oncogenic Src, Ras, and Raf
(Abate et al., 1990; Binetruy et al., 1991; Boyle et al.,
1991; Frame et al., 1991; Lin et al., 1992; Pulverer et al.,
1991; Smeal et al., 1991; Derijard et al., 1994; Kyriakis
et al., 1994). We have previously examined the early
regulation of AP-1 in resting CEF that are induced to
reenter cycle and transform upon activation of temper-
ature sensitive (ts) v-Src (Catling et al., 1993). DNA
binding and transactivation are stimulated soon after
shift to permissive temperature, effects are mediated
partly by enhanced transcription of c-fos and altered
phosphorylation of c-Jun. A nonmyristylated ts v-Src
protein does not stimulate AP-1 activity, is transfor-
mation-defective, and is unable to induce CEF to reenter
cycle, implying that crucial signaling events at the
membrane are required for the early increase in AP-1
activity that accompanies v-Src-induced mitogenesis
and transformation. In rat fibroblasts AP-1 activity is
also enhanced in response to activation of v-Src, al-
though this is not mediated by increased synthesis of
c-fos or c-jun transcripts (Welham et al., 1990). Thus,
stimulation of AP-1 correlates with v-Src activity in a
number of settings, although achieved by different
mechanisms, implying an important role for AP-1
regulated genes in the biological consequences of
v-Src.
Dimerization of the components of AP-1 is mediated
by the leucine repeats of Jun and Fos and is essential
for DNA binding. Fos does not homodimerize and so
does not bind to DNA independently of Jun, whereas
Jun is able to form homodimers and heterodimers with
Fos, the latter having greater stability and higher affinity
for the specific DNA recognition sequence (reviewed in
Gillespie, 1991). These properties of AP-1 have allowed
the design of inhibitory mutants of Fos and Jun that are
able to dimerize with their cellular partners but form
nonfunctional complexes because of their inability to
bind to DNA and lack of sequences normally associated
with transactivation function. Such mutants have been
used to demonstrate a role for AP-1 in transformation
of chick embryo fibroblasts (CEF) by c-jun (Okuno et
al., 1991) and transformation of rat embryo cells by
activated ras and deregulated c-jun and c-fos genes
(Brown et al., 1993).
In this present study we have examined the effects
of expressing a mutated Fos protein on the mitogenic
and morphological activities of v-Src. We conclude
that AP-1 stimulation is required for mitogenesis but
not the ultrastructural changes that give rise to the
morphological appearance of v-Src-transformed cells.
This implicates AP-1 as a nuclear target for the mi-
togenic pathway but not the cytoskeletal/morpho-
logical pathway initiated by v-Src and shows that
these two pathways are, at least in part, biochemically
separable.
MATERIALS AND METHODS
Cloning and Expression of c-fos Mutant
with ts v-Src in CEF
The replication competent avian retrovirus (RCAN) expressing the ts
mutant of v-Src, LA 29, was constructed as described previously (Ca-
tling et al., 1993). Standard polymerase chain reaction (PCR) tech-
nology was used to obtain the basic and leucine zipper coding se-
quences of murine c-fos (amino acids 111-206) containing four codons
that give rise to insertion of the amino acid sequence PLER (in the
single letter amino acid code) at amino acid 161 in the murine c-Fos
sequence. A Kozak consensus was incorporated into the 5' primer to
ensure efficient transcription initiation. HindIII and BamHI sites were
included in the 5' and 3' primers, respectively, to allow ligation with
a BamHI/Eco Rl fragment encoding the HE14 portion of the human
estrogen receptor (ER) and the pSFCV-LE-Sa+ vector (Fuerstenberg
et al., 1990) cut with HindIII and EcoRI (Figure 1A). The cloned PCR
product was confirmed by sequencing. Plasmids used in cell trans-
fection experiments were purified through caesium chloride gradients.
Sequences encoding the HE14 portion of the human ER (Kumar et
al., 1986), preceded by an initiating methionine codon, were also cloned
into pSFCV as control.
Primary CEF cultures were grown and cotransfected at low density
with RCAN-Src construct (5-10 Mg per 25-cm2 flask) and pSFCV-
6Fosi-ER fusion construct (10 jig per 25-cm2 flask) at restrictive tem-
perature (41°C) using the calcium phosphate method. Growth and
transfection were as described in Crouch et al., 1990 with the addition
of 1 AM f-oestradiol. Transfected cultures were selected in G418 and
found to uniformly express v-Src and the ER fusion proteins by im-
munoblotting using anti-Src monoclonal EC10 (Tissue Culture Ser-
vices, UK) and the anti-ER monoclonal (F3-A) (Euromedex, Schil-
tighein, France) (Figure 1B).
Electrophoretic Mobility Shift Assay (EMSA)
Total cell protein extracts were prepared as described in Marais et al.
(1993). Briefly, whole cell extracts were prepared from 90-mm dishes
of cells. The cells were washed twice with phosphate-buffered saline
(PBS) and lysed with 50 Ml extract buffer. Extracts were sonicated and
clarified by high speed centrifugation; protein concentration of su-
pernatants was determined by the Bio-Rad Laboratories (Richmond,
CA) protein assay kit and stored at -70°C. Ten micrograms of cell
extract was incubated for 30 min on ice with a radiolabeled oligo-
nucleotide containing the AP-1 consensus from the collagenase pro-
moter. Incubation buffers and acrylamide gels were as described in
Frame et al. (1991). Similar results to those found with AP-1 DNA
binding activities from whole cell extracts were obtained using proteins
extracted from purified nuclei (unpublished observations).
Mitogenesis
Low density cultures were made quiescent at restrictive temperature
by incubating in 0.2% serum for 48-72 h. DNA synthesis was mea-
sured at various times after stimulation by pulse labeling with tritiated
methylthymidine (Amersham, Arlington Heights, IL) as described
previously (Welham et al., 1990).
Protein Immunoblotting (Including Focal Adhesion
Kinase [FAKJ Detection)
Proteins resolved by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) were transferred to nitrocellulose using a
semidry blot procedure. After appropriate blocking (3% Marvel or
3% bovine serum albumin for anti-phosphotyrosine blots with 0.2%
Tween 20 [Sigma, St. Louis, MO]) overnight at 4°C, blots were in-
cubated with the primary antisera, washed extensively with PBS/
0.2% Tween 20, and incubated with 1:5000 horse radish peroxidase-
conjugated anti-mouse or anti-rabbit serum (Amersham). Reactive
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proteins were visualised using enhanced chemiluminesence according
to the manufacturer's instructions (Amersham). Primary antisera were
used at the following concentrations: anti-Src EC10, 1:5000; anti-ER,
1:1000; anti-phosphotyrosine (Upstate Biotechnology, Lake Placid,
NY), 1:5000.
CEF protein lysates for immunoprecipitation were prepared in RIPA
buffer (Black et al., 1991) as described previously (Catling et al., 1993).
Before immunoprecipitation, lysates were clarified by centrifugation
at 14 000 rpm in a Sorvall SS34 rotor (Newton, CT) for 20 min at
4°C, precleared with 10 Al of normal rabbit serum and protein A-
sepharose (Sigma). FAK was immunoprecipitated from 300-500 sg
protein by incubating with 2 ,l anti-FAK (Upstate Biotechnology)
overnight on ice. Immunoprecipitated FAK was collected on protein
A-sepharose beads coated with rabbit anti-mouse IgG. Proteins were
resolved by 7.5% SDS-PAGE, immunoblotted, and probed with anti-
phosphotyrosine IgG.
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Cloning and Expression of the c-fos Mutant
We have used an approach similar to that of other
groups to inhibit AP-1 by expression of an interfering
mutant of c-Fos. The mutant was designed to bind to
its cellular partners from the Jun family of proteins but
form dimers that could not bind to the AP-1 recognition
sequence. We made use of the published, observations
that the leucine zipper andDNA binding domains were
sufficient to specify dimerization and DNA contact in
the absence of the rest of the proteins (Abate et al.,
1990). Thus, a region of c-fos encoding the entire leucine
zipper and basic DNA binding domain, which contained
a four amino acid helix disrupting insertion between
the basic region and leucine zipper, was cloned into
SFCV (5Fosi) (described in MATERIALS AND METH-
ODS). Insertion of codons for the same four amino acids
into c-fos coding sequences has been shown to disrupt
Fos function and inhibit cellular AP-1 in a dominant
manner (Yoshida et al., 1989, Okuno et al., 1991). The
c-fos sequences were fused to the HE14 portion of the
human ER (Figure 1A), providing an epitope tag. As
control, the HE14 domain preceded by an initiating me-
thionine codon was also introduced into SFCV (mER)
(Figure 1A). These constructs were cotransfected into
CEF with the replication competent retroviral vector
RCAN encoding the ts v-Src mutant LA29. After selec-
tion with G418, the cell lysates were probed with Src-
and ER-specific antibodies. As expected, the cells were
uniformly infected with the v-Src-expressing retrovirus
(Figure 1B, lanes 6 and 7). Cells transfected with the
6Fosi-ER and mER constructs expressed proteins of the
expected molecular weights that reacted with the ER
antibody (Figure 1B, lanes 2 and 3, respectively). Cells
transfected with 5Fosi-ER also consistently produced
proteins with lower apparent molecular weights, per-
haps indicating cleavage within the cell (Figure 1B, lane
3). The bFos,-ER and mER coding sequences were sub-
cloned into a transcription vector and transcribed and
translated in vitro, both constructs giving rise to trans-
lation products of the predicted size (unpublished ob-
WFosiER
->
mER >
1 2 3 4 5 6 7
Figure 1. (A) Construction of pSFCV-mER and pSFCV-5Fosj-ER.
The murine c-fos basic region (B) and leucine zipper (LZ) coding se-
quences, containing a four-amino-acid PLER insertion, were isolated
by PCR and cloned into the pSFCV-Sa+ avian retroviral vector as
described in MATERIALS AND METHODS. Coding sequences for
the HE14 portion of the human ER were also cloned into pSFCV as
control (mER). Other functional domains of c-Fos shown are the reg-
ulatory regions (R) and regions required for trans-activation (-). (B)
Expression of mER and 6Fosi-ER fusion proteins with ts v-Src. Extracts
of growing CEF were prepared and immunoblotted using anti-ER
(A/ER) (lanes 1-3) or EC10 (A/Src) (lanes 4-7). Three hundred mi-
crograms protein from CEF-expressing SFCV vector alone (lane 1),
mER (lane 2), or 5Fos,-ER (lane 3), all coexpressing ts v-Src, were
separated by SDS-PAGE, blotted, and probed with A/ER. Arrows
show the species that comigrated with the primary translated products
when translated in vitro. One hundred micrograms protein from CEF-
expressing ts v-Src (lanes 4, 6, and 7), or RCAN vector alone (lane
5), with SFCV vector alone (lanes 4 and 5), mER (lane 6), or 6Fosi-ER
(lane 7), were immunoblotted using A/Src. v-Src protein is shown
by the arrow.
servations). The hormone responsive sequences from
the ER are frequently used to confer oestradiol-depen-
dent conditionality on heterologous protein function.
One micromolar f3-oestradiol was therefore routinely
added to the culture medium with no effect on cell
growth rate or viability. We have no evidence that the
function of the c-Fos mutant was made conditional by
the ER fusion.
AP-1 Inhibitory Properties of the c-fos Mutant
Cells cotransfected with the mER or 5Fosi-ER constructs
and RCAN-ts v-Src were characterized with respect to
Vol. 5, November 1994
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their endogenous AP-1 DNA-binding activity. Extracts
of cells growing exponentially were prepared and tested
for their ability to bind to a labeled oligonucleotide con-
taining a single AP-1 site using EMSAs. A decrease in
AP-1 DNA-binding activity relative to the mER control
cells was consistently observed with cells expressing
6Fosi-ER (Figure 2, lane 2), although there always re-
mained appreciable AP-1 DNA-binding activity. The
specificity of the AP-1 DNA-binding complex was con-
firmed by inhibition with unlabeled competitor (Figure
2, lanes 3 and 4). Thus, expression of 6Fosi-ER resulted
in a partial inhibition of cellular AP-1 activity in growing
CEF that had no obvious effect on cell growth.
We next examined the ability of activation of ts v-Src
to stimulate AP-1 DNA binding in CEF expressing mER
and 6Fos8-ER and made quiescent by serum deprivation.
The mER control cells responded to a shift to permissive
temperature by stimulation of AP-1 DNA binding, seen
1 h after temperature shift (Figure 3, lanes 2-4), an effect
that we previously found to occur only in response to
biologically active mutants of v-Src (Catling et al., 1993).
In contrast, cells transfected with eFosi-ER exhibited a
reduced ability to stimulate AP-1 DNA binding in
quiescent cells after v-Src activation (Figure 3, lanes 6-
8). Thus, although AP-1 activity in cycling cells was
only partially inhibited by bFosi-ER, the ability of v-Src
to stimulate AP-1 in quiescent cells was suppressed to
a considerably greater extent.
The Effect of the c-fos Mutant on v-Src-induced
Mitogenesis
CEF expressing ts v-Src with the control mER or mutant
Fos protein were made quiescent as described above
and either unstimulated (Figure 4A) or stimulated either
by shift to permissive temperature in the absence of
additional factors (Figure 4B) or by the addition of new-
~$,~<Ob. MER
- - - + competitor
AP-1 ->
1 2 3 4
Figure 2. AP-1 DNA-binding activity in growing CEF. EMSAs were
carried out as described in MATERIALS AND METHODS using a
labeled collagenase AP-1 probe and extracts from CEF-expressing
mER or 6Fos,-ER (lanes 1 and 2, respectively). Competition with 100-
fold excess unlabeled homologous competitor demonstrated specificity
(lanes 3 and 4). Retarded AP-1 probe is indicated by the arrow.
mER 8Fos.ER
0 1 2 4 0 1 2 4 h
AP-1
1 2 3 4 5 6 7 8
Figure 3. Inhibition of AP-1 stimulation in response to activation
of ts v-Src. EMSAs carried out using extracts prepared from CEF-
expressing mER (lanes 1-4) or bFos,-ER (lanes 5-8) that had been
made quiescent and stimulated by shift to permissive temperature for
1 h (lanes 2 and 6), 2 h (lanes 3 and 7), and 4 h (lanes 4 and 8),
respectively.
born calf serum (5%) (Figure 4C). During the course of
the experiment, the levels of thymidine uptake for both
transfectants remained low and invariant in the absence
of any stimulus (Figure 4A). In the mER control cells,
activation of v-Src and serum addition resulted in entry
into S-phase as measured by uptake of tritiated thy-
midine (Figure 4, B and C). Cells expressing bFosi-ER
exhibited a reduced capacity to reenter cell cycle in re-
sponse to either addition of serum or temperature shift
(Figure 4, B and C). The extent of inhibition of mito-
genesis in response to v-Src and serum varied between
batches of CEF prepared at different times and de-
pended on them being properly quiescent after serum
deprivation.
Morphological Transformation Is Unaffected
by AP-1 Inhibition
To address the role of AP-1 stimulation in the v-Src-
mediated morphological changes, CEF coexpressing the
c-Fos mutant protein with ts v-Src were made quiescent
at restrictive temperature and either retained at restric-
tive temperature or shifted to permissive temperature
for 24-36 h. At 41°C all cultures were flat with the
typical appearance of normal CEF (Figure 5, A and B).
After shift to 35°C, the morphological appearance of
the cultures stably transfected with mER or bFosi-ER
was identical, with both exhibiting the refractile irregular
features of v-Src-transformed CEF (Figure 5, C and D).
Thus, AP-1 stimulation is not required for the morpho-
logical aspects of v-Src-induced transformation, imply-
ing that the mitogenic and morphological consequences
of v-Src activity are biochemically separable.
FAK Activation by v-Src Is Unaffected
by AP-1 Inhibition
p125 FAK, a recently identified nonreceptor protein ty-
rosine kinase present in cellular adhesion plaques that
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Figure 4. Effect of c-Fos mutant on mitogenesis. Thyr
of CEF coexpressing ts v-Src with mER or bFos%-ER t
made quiescent by serum deprivation at restrictive ten
either retained at restrictive temperature (A, CONTRC
permissive temperature (B, TEMPERATURE SHIFT), or
5% newborn calf serum (C, SERUM).
is itself activated by tyrosine phosphorylat
plicated in mediating the cytoskeletal chang(
rise to the morphological appearance of tr
cells (Schaller et al., 1992). Thus, we examin
phosphorylation of p125 FAK in response tc
of ts v-Src in CEF transfected with the inhib
ER construct. FAK was immunoprecipitatei
lysates, the proteins were separated by SDS-
immunoblotted with anti-phosphotyrosine
In quiescent cells coexpressing v-Src with:
strictive temperature (Figure 6, lane 2), tyrc
phorylation of FAK was considerably above
not expressing v-Src (control RCAN vector
lane 1). In response to shift to permissive t4
for 24 h, FAK appeared to undergo a gel mobility shift
to an apparently higher molecular weight (Figure 6, lane
3), presumably as a result of hyperphosphorylation
and/or a conformational change. These observations
are in agreement with previous reports that increased
x mER phosphorylation of p125 is characterized by a shift in
* WFos,ER gel mobility in cells transformed by activated variants
of c-src and v-src (Kanner et al., 1990; Seidel-Dugan et
al., 1992). We are not able to conclude whether the total
phosphotyrosine content of p125 was increased in re-
x mER sponse to activation of v-Src in these experiments be-
cause the immunoblots were not titrated. In CEF trans-
fected with bFosi-ER, the change in gel mobility of FAK
in response to activation of v-Src was similar to the
mER control (Figure 6, lanes 4 and 5), indicating that
the posttranslational alteration of FAK that gives rise to
the change in migration on SDS-PAGE does not require
* WFos.ER the early stimulation in AP-1 activity that normally ac-
companies v-Src activation.
DISCUSSION
In this study we have used a mutant of c-fos encoding
a protein that interferes with the normal regulation of
the cellular transcription factor AP-1 to examine the
x mER need for AP-1 in v-Src-induced mitogenesis and mor-
phological transformation. Stable expression of the c-
Fos leucine zipper and disrupted basic region, fused to
the HE14 portion of the human ER, substantially re-
duced the early v-Src-induced stimulation of AP-1 in
* oFosjER cells made quiescent by serum deprivation but not in
cells growing exponentially. This AP-1 reduction was
accompanied by a marked impairment of v-Src-driven
exit of quiescent cells from Go.
These observations parallel closely those of Nishikura
.nidin upte and Murray (1987), who showed that NIH3T3 cells ex-hadneadpbekn pressing antisense fos cycled almost normally in expo-
nperature and nential growth but were unable to leave Go and reenter
)L), shifted to cycle in response to platelet-derived growth factor. An
provided with antisense approach has also demonstrated a need for
AP-1 in the mitogenic response of target cells to tumour
necrosis factor-a (Brach et al., 1993). These observations,
with ours, indicate that AP-1 stimulation is a general
tion, is im- prerequisite for the transition from Go to Gl, although
es that give this early AP-1 activation is not sufficient for cells to
ransformed enter S-phase in the absence of other factors, because
Led tyrosine there is a second requirement for v-Src activity in mid-
) activation G, (Wyke et al., 1993).
iitory 6Fosi- We also found that in CEF transfected with dominant
d from cell negative Fos the morphological changes characteristic
-PAGE and of v-Src transformation were unimpaired, showing that
antibodies. AP-1 activation is a specific and necessary nuclear con-
mER at re- sequence of v-Src activity that is dispensable for mor-
)sine phos- phological transformation. This finding is ostensibly at
that in cells variance with the conclusions of some previous work.
) (Figure 6, Expression of antisense fos RNA partially inhibits ras-
emperature induced transformation (Ledwith et al., 1990), yet an-
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Figure 5. Morphology of
quiescent CEF cultures ex-
pressing mER (A and C) or
6Fos,-ER (B and D) at restrictive
(A and B) and permissive (C
and D) temperatures.
tibodies to p21 Ras inhibit v-Src transformation (Smith
et al., 1986), implying that Ras function is needed for
v-Src to transform cells. In addition, several groups
(Kouzarides and Ziff, 1988; Gentz et al., 1989; Okuno
et al., 1989; Ransone et al., 1990; Smeal et al., 1989;
Turner and Tjian, 1989) have reported derivatives of
both c-Fos and c-Jun that act as transdominant inhibitors
of AP-1 of the kind that have been shown to suppress
oncogene-induced transformation. In particular, a c-jun
dominant negative mutant suppressed transformation
of rat embryo cells induced by oncogenic ras or dereg-
ulated c-jun or c-fos (Brown et al., 1993). This is consis-
tent with other reports of Jun and Fos proteins inter-
fering with ras transformation (Lloyd et al., 1991; Wick
et al., 1992), although in the latter case the inhibition
may have been by mechanisms other than direct re-
duction in AP-1-dependent transactivation. The con-
sensus that v-Src requires Ras activity and that the latter
acts through AP- 1 can only be partially reconciled with
our finding that AP-1 is dispensable for v-Src transfor-
mation by postulating that Ras mediates aspects of
v-Src activity independently of AP-1. These AP-1-in-
dependent activities must be insufficient for Ras trans-
formation but adequate for transformation by v-Src,
possibly because v-Src has other Ras- and AP-1-inde-
pendent effects.
Our conclusion that v-Src-induced mitogenesis and
transformation are at least partly separable, although
not predicted by the findings discussed above, are, in
fact, supported by several earlier observations. Non-
myristylated v-Src mutants were nontransforming but
promoted proliferation of neuroretinal cells (Calothy et
al., 1987), although the same mutants were nonmito-
genic for quiescent CEF as used in this study (Catling
et al., 1993). In addition, some ts mutants dissociated
morphological changes from growth-related parameters
such as cell density and serum- and anchorage-inde-
pendent multiplication (Weber and Friis, 1979). The
correlates of mitogenesis used in these studies were,
however, relatively poorly understood and cannot be
readily equated with the transit out of Go that we have
examined. Closer parallels for our findings were the ob-
servations of Beug et al. (1978), who reported that ts
v-Src mutants can transform enucleated cells, and sev-
eral studies showing that transformation by ts mutants
occurred when de novo transcription was suppressed
by Actinomycin D (Kawai and Hanafusa, 1971; Bader,
1972; Biquard and Vigier, 1972). Such work clearly
showed that nuclear functions are not required for some
effects of v-Src at the cell periphery, but the indiscrim-
inate ablation of nuclear activity precludes both the
prolonged observation and further dissection of the
phenomenon that are permitted by our approach.
Our initial observations on FAK exemplify this po-
tential for further analysis. FAK, a protein tyrosine ki-
nase present in cellular adhesion plaques, is believed to
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Quiescent CEF
+ + ts v-Src
mER 6FosjER
350 410 350 41° 35°
FAK
p97
Ig
1 2 3 4 5
Figure 6. Activation of FAK in response to activation of ts v-Src.
FAK was immunoprecipitated from CEF-expressing RCAN and SFCV
vectors as control (lane 1), CEF coexpressing ts v-Src with mER (lanes
2 and 3), or 6Fos1-ER (lanes 4 and 5), separated by SDS-PAGE, blotted,
and probed with anti-phosphotyrosine. Before harvesting for im-
munoprecipitation, the cells had been made quiescent by serum de-
privation at the restrictive temperature of 41°C and maintained at
this temperature (lanes 2 and 4) or shifted to the permissive temper-
ature of 35°C for 18 h. The faster and slower migrating forms of FAK
are shown by the arrows. The 97-kDa molecular weight protein marker
and the anti-FAK immunoglobulin (Ig) present in the immunoprecp-
itate are also shown.
play an important role in the ultrastructural changes
that occur at the G2-M transition during the cell cycle,
when c-Src is active, and in response to the v-Src-
transforming protein (reviewed in Zachary and Roz-
engurt, 1992; Schaller and Parsons, 1993). p125 FAK
is a cytoplasmic target for oncogenically active forms
of Src that result in elevated FAK tyrosine phosphor-
ylation and activity (Kanner et al., 1990). A complex
between FAK and Src, both members of the nonreceptor
class of protein tyrosine kinases, is mediated by the Src
SH2 domain and the major site of autophosphorylation
in FAK (Schaller et al., 1994). Activation of FAK and/
or translocation of active Src to focal adhesions may
lead to enhanced tyrosine phosphorylation of other
components of focal adhesions, for example, vinculin
and paxillin, both known to exhibit increased tyrosine
phosphorylation in v-Src-transformed cells (Sefton et
al., 1981; Glenney and Zokas, 1989). The lack of effect
of AP-1 inhibition on the v-Src-mediated effects on
FAK implies that its hyperphosphorylation, and pre-
sumed activation, is independent of this early nuclear
consequence of v-Src activity. However, it is not yet
known whether FAK itself provides a signal that is
transmitted to the nucleus and alters expression of genes
involved in uncontrolled growth or other tumor-asso-
ciated properties, such as invasion or angiogenesis. It
seems likely that, although v-Src mitogenic and mor-
phological effects are partially separate in vitro, full
transformation in vivo will need cell growth and hence
the activation of both pathways. These concepts are in
keeping with a recent detailed study by Miao and Cur-
ran (1994) on the kinetics of transformation by c-fos
that indicated that, although AP-1 function may con-
tribute to the transforming activities of src, c-Fos alone
cannot be fully responsible for all aspects of the trans-
formed phenotype. The ability to ablate specific nuclear
consequences of v-Src activity will permit dissection of
the interplay between this oncoprotein's mitogenic and
morphological transforming properties.
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